SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0000950134-06-003074
Filing Date
2006-02-14
Accepted
2006-02-14 17:43:01
Documents
3
Group Members
ALEXANDER E BARKASDAVID SCHNELLJAMES B TANANBAUMPROSPECT MANAGEMENT CO III LLCRUSSELL C HIRSCH

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D f17398sc13d.htm SC 13D 135156
2 EXHIBIT 99.A f17398exv99wa.htm EX-99.A 184006
3 EXHIBIT 99.B f17398exv99wb.htm EX-99.B 8653
  Complete submission text file 0000950134-06-003074.txt   329821
Mailing Address 60 WESTVIEW STREET LEXINGTON MA 02421
Business Address 60 WESTVIEW STREET LEXINGTON MA 02421 781-402-5700
CRITICAL THERAPEUTICS INC (Subject) CIK: 0001145404 (see all company filings)

IRS No.: 043523569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-79887 | Film No.: 06617983
SIC: 2834 Pharmaceutical Preparations

Mailing Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301
Business Address 435 TASSO ST SUITE 200 PALO ALTO CA 94301 650-327-8800
Prospect Venture Partners III L P (Filed by) CIK: 0001311490 (see all company filings)

IRS No.: 000000000
Type: SC 13D